https://doi.org/10.4081/reumatismo.2009.212

Infliximab treatment in a case of rheumatoid scleromalacia perforans

Vol. 61 No. 3 (2009)
Abstract Views: 1053
PDF: 870
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

R. Herrera-Esparza
office@pagepress.org
E. Avalos-Diaz
Rheumatoid disease can cause ocular inflammation of the conjunctiva, sclera, and uveal tract. The sclera is an avascular layer covered by the episclera that is highly vascularised and can be affected by inflammation. Frequently, ophthalmic involvement in rheumatoid arthritis (RA) and spondyloartrhophaties results of a systemic and chronic inflammation that can produce devastating effects. Clinically, episcleritis looks similar to conjunctivitis, although there is no discharge. A common symptom of episcleritis is redness, and patients may also complain of foreign body...

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC

How to Cite

Herrera-Esparza, R., & Avalos-Diaz, E. (2009). Infliximab treatment in a case of rheumatoid scleromalacia perforans. Reumatismo, 61(3), 212–215. https://doi.org/10.4081/reumatismo.2009.212

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.